CPIX (Cumberland Pharmaceuticals Inc) Stock Analysis - Analyst Ratings

Cumberland Pharmaceuticals Inc (CPIX) is a publicly traded Healthcare sector company. As of May 21, 2026, CPIX trades at $5.41 with a market cap of $76.71M and a P/E ratio of -11.37. CPIX moved +1.85% today. Year to date, CPIX is +38.25%; over the trailing twelve months it is +9.94%. Its 52-week range spans $1.04 to $7.25. Rallies surfaces CPIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CPIX?

The average price target is $0.00.

CPIX Key Metrics

Key financial metrics for CPIX
MetricValue
Price$5.41
Market Cap$76.71M
P/E Ratio-11.37
EPS$-0.49
Dividend Yield0.00%
52-Week High$7.25
52-Week Low$1.04
Volume509
Avg Volume0
Revenue (TTM)$41.94M
Net Income$-7.40M
Gross Margin82.89%

CPIX Analyst Consensus

CPIX analyst coverage data. Average price target: $0.00.

Latest CPIX News

Recent CPIX Insider Trades

  • Young Caroline bought 6 (~$20.7) on Aug 29, 2025.
  • Jones James bought 13 (~$44.85) on Aug 29, 2025.
  • KAZIMI A J bought 13 (~$44.85) on Aug 29, 2025.

Common questions about CPIX

What do analysts rate CPIX?
The average price target is $0.00.
Does Rallies show CPIX price targets?
Yes. Rallies tracks CPIX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CPIX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CPIX. It does not provide personalized investment advice.
CPIX

CPIX